These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 8690587)

  • 1. Estimation of radiation doses for atomic-bomb survivors in the Hiroshima University Registry.
    Hoshi M; Matsuura M; Hayakawa N; Ito C; Kamada N
    Health Phys; 1996 May; 70(5):735-40. PubMed ID: 8690587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies of the mortality of A-bomb survivors. 9. Mortality, 1950-1985: Part 1. Comparison of risk coefficients for site-specific cancer mortality based on the DS86 and T65DR shielded kerma and organ doses.
    Shimizu Y; Kato H; Schull WJ; Preston DL; Fujita S; Pierce DA
    Radiat Res; 1989 Jun; 118(3):502-24. PubMed ID: 2727272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of possible modifications to the DS86 dosimetry on neutron risk and relative biological effectiveness.
    Hunter N; Charles MW
    J Radiol Prot; 2002 Dec; 22(4):357-70. PubMed ID: 12546224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A review of forty-five years study of Hiroshima and Nagasaki atomic bomb survivors. Radiation cataract.
    Otake M; Schull WJ
    J Radiat Res; 1991 Mar; 32 Suppl():283-93. PubMed ID: 1762117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiation-related posterior lenticular opacities in Hiroshima and Nagasaki atomic bomb survivors based on the DS86 dosimetry system.
    Otake M; Schull WJ
    Radiat Res; 1990 Jan; 121(1):3-13. PubMed ID: 2300666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reassessment of the cancer mortality risk among Hiroshima atomic-bomb survivors using a new dosimetry system, ABS2000D, compared with ABS93D.
    Katayama H; Matsuura M; Endo S; Hoshi M; Ohtaki M; Hayakawa N
    J Radiat Res; 2002 Mar; 43(1):53-64. PubMed ID: 12056330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of cancer mortality among atomic bomb survivors registered at Hiroshima University.
    Matsuura M; Hoshi M; Hayakawa N; Shimokata H; Ohtaki M; Ikeuchi M; Kasagi F
    Int J Radiat Biol; 1997 May; 71(5):603-11. PubMed ID: 9191905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A review of forty-five years study of Hiroshima and Nagasaki atomic bomb survivors. Theoretical background of the Dosimetry System 86 (D586).
    Kosako T
    J Radiat Res; 1991 Mar; 32 Suppl():11-9. PubMed ID: 1762097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dosimetric Impact of a New Computational Voxel Phantom Series for the Japanese Atomic Bomb Survivors: Methodological Improvements and Organ Dose Response Functions.
    Sato T; Funamoto S; Paulbeck C; Griffin K; Lee C; Cullings H; Egbert SD; Endo A; Hertel N; Bolch WE
    Radiat Res; 2020 Oct; 194(4):390-402. PubMed ID: 33045092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fetal atomic bomb survivor dosimetry using the J45 series of pregnant female phantoms with realistic survivor exposure scenarios: comparisons to dose estimates in the DS02 system.
    Paulbeck CJ; Sato T; Funamoto S; Lee C; Griffin KT; Cullings HM; Egbert SD; Endo A; Hertel NE; Bolch WE
    Radiat Environ Biophys; 2023 Aug; 62(3):317-329. PubMed ID: 37296237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose-response relationship of neutrons and gamma rays to leukemia incidence among atomic bomb survivors in Hiroshima and Nagasaki by type of leukemia, 1950--1971.
    Ishimaru T; Otake M; Ischimaru M
    Radiat Res; 1979 Feb; 77(2):377-94. PubMed ID: 286375
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of recent changes in atomic bomb survivor dosimetry on cancer mortality risk estimates.
    Preston DL; Pierce DA; Shimizu Y; Cullings HM; Fujita S; Funamoto S; Kodama K
    Radiat Res; 2004 Oct; 162(4):377-89. PubMed ID: 15447045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of the DS86 atomic bomb radiation dosimetry methods using data on severe epilation.
    Stram DO; Mizuno S
    Radiat Res; 1989 Jan; 117(1):93-113. PubMed ID: 2913611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An analysis of various aspects of atomic bomb dose estimation at RERF using data on acute radiation symptoms.
    Gilbert ES; Ohara JL
    Radiat Res; 1984 Oct; 100(1):124-38. PubMed ID: 6494426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent uses of biological data for the evaluation of A-bomb radiation dosimetry.
    Stram DO; Sposto R
    J Radiat Res; 1991 Mar; 32 Suppl():122-35. PubMed ID: 1762098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies of the mortality of A-bomb survivors. 9. Mortality, 1950-1985: Part 2. Cancer mortality based on the recently revised doses (DS86).
    Shimizu Y; Kato H; Schull WJ
    Radiat Res; 1990 Feb; 121(2):120-41. PubMed ID: 2305030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neutron relative biological effectiveness in Hiroshima and Nagasaki atomic bomb survivors: a critical review.
    Sasaki MS; Endo S; Hoshi M; Nomura T
    J Radiat Res; 2016 Nov; 57(6):583-595. PubMed ID: 27614201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of changes in dosimetry on cancer mortality risk estimates in the atomic bomb survivors.
    Preston DL; Pierce DA
    Radiat Res; 1988 Jun; 114(3):437-66. PubMed ID: 3375435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospects and status of the dosimetry system for atomic bomb survivor cohort study conducted at Research Institute for Radiation Biology and Medicine of Hiroshima University.
    Hirota S; Yasuda H; Kawakami H; Yoshinaga S
    J Radiat Res; 2021 May; 62(Supplement_1):i107-i113. PubMed ID: 33978168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leukemia: lessons from the Japanese experience.
    Finch SC
    Stem Cells; 1997; 15 Suppl 2():135-9. PubMed ID: 9368297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.